All News Immatics N.V.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
12.7 ^USD	+3.76%		+8.18%	+20.61%

May. 15	Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating	MT
May. 14	Immatics' Q1 Loss Narrows. Revenue Rises	MT

MEMO THERAPEUTICS AG APPOINTS PAUL CARTER AS CHAIRPERSON	Jul. 09	AQ
Immatics N : MINUTES OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF IMMATICS N.V Form 6 K	Jun. 20	PU
Immatics N : CONVENING NOTICE OF the ANNUAL GENERAL MEETING OF IMMATICS N.V - Form 6-K	Jun. 03	PU
Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating	May. 15	MT
Immatics' Q1 Loss Narrows. Revenue Rises	May. 14	MT
Immatics: Q1 Earnings Snapshot	May. 14	AQ
Immatics N : Corporate Presentation May 2024	May. 14	PU
Immatics Announces First Quarter 2024 Financial Results and Business Update	May. 14	GL
Immatics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Certain Ordinary Shares of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	Apr. 16	CI
Certain Warrants of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	Apr. 16	CI
Certain Options of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	Apr. 16	CI
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	Mar. 21	MT
Sector Update: Health Care	Mar. 21	MT
Immatics Swings to 2023 Net Loss, Revenue Falls -- Shares Down Pre-Bell	Mar. 21	MT
Immatics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Immatics N : Corporate Presentation March 2024	Mar. 21	PU
Immatics Announces Full Year 2023 Financial Results and Corporate Update	Mar. 21	GL
Sector Update: Health Care Stocks Mixed Premarket Thursday	Jan. 18	MT
Immatics Prices $175 Million Share Offering	Jan. 18	MT

No results for this search